BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saini A, Wallace A, Alzubaidi S, Knuttinen MG, Naidu S, Sheth R, Albadawi H, Oklu R. History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma. J Clin Med 2019;8:E55. [PMID: 30621040 DOI: 10.3390/jcm8010055] [Cited by in Crossref: 27] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Talebi AS, Rajabi H. Outcomes following transarterial radioembolization with 90Y and nanoparticles loaded resin microspheres. Appl Radiat Isot 2022;188:110405. [PMID: 35987141 DOI: 10.1016/j.apradiso.2022.110405] [Reference Citation Analysis]
2 Lu J, Zhu D, Zhang X, Wang J, Cao H, Li L. The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease. Clin Transl Oncol. [DOI: 10.1007/s12094-022-02943-3] [Reference Citation Analysis]
3 Aguado A. Role of Interventional Radiology in Pediatric Cancer Patients. Curr Oncol Rep 2022. [PMID: 36057070 DOI: 10.1007/s11912-022-01320-1] [Reference Citation Analysis]
4 Som A, Rosenboom JG, Chandler A, Sheth RA, Wehrenberg-Klee E. Image-guided intratumoral immunotherapy: Developing a clinically practical technology. Adv Drug Deliv Rev 2022;:114505. [PMID: 36007674 DOI: 10.1016/j.addr.2022.114505] [Reference Citation Analysis]
5 Garg T, Shrigiriwar A, Habibollahi P, Cristescu M, Liddell RP, Chapiro J, Inglis P, Camacho JC, Nezami N. Intraarterial Therapies for the Management of Hepatocellular Carcinoma. Cancers (Basel) 2022;14:3351. [PMID: 35884412 DOI: 10.3390/cancers14143351] [Reference Citation Analysis]
6 Gao F, Wang Y, Huang X, Pan T, Guo J. I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02356-0] [Reference Citation Analysis]
7 Karahan Şen NP, Alataş Ö, Gülcü A, Özdoğan Ö, Derebek E, Çapa Kaya G. The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer. Nucl Med Commun 2022. [PMID: 35506284 DOI: 10.1097/MNM.0000000000001572] [Reference Citation Analysis]
8 Viñal D, Minaya-Bravo A, Prieto I, Feliu J, Rodriguez-Salas N. Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies. Clin Transl Oncol 2022;24:796-808. [PMID: 35013882 DOI: 10.1007/s12094-021-02745-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Waddell JJ, Townsend PH, Collins ZS, Walter C. Liver-Directed Therapy for Metastatic Colon Cancer: Update. Curr Colorectal Cancer Rep 2022;18:18-25. [DOI: 10.1007/s11888-022-00474-1] [Reference Citation Analysis]
10 Talebi AS, Rajabi H, Watabe H. Role of nanoparticles in transarterial radioembolization with glass microspheres. Ann Nucl Med 2022. [PMID: 35199286 DOI: 10.1007/s12149-022-01727-7] [Reference Citation Analysis]
11 Páramo M, Santamaría E, Idoate MA, Rodríguez-Fraile M, Benito A, Collantes M, Quincoces G, Peñuelas I, Berasain C, Argemi J, Quiroga J, Sangro B, Bilbao JI, Iñarrairaegui M. A new animal model of atrophy-hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits. Sci Rep 2022;12:1777. [PMID: 35110610 DOI: 10.1038/s41598-022-05672-3] [Reference Citation Analysis]
12 Hu J, Albadawi H, Zhang Z, Salomao MA, Gunduz S, Rehman S, D'Amone L, Mayer JL, Omenetto F, Oklu R. Silk Embolic Material for Catheter-Directed Endovascular Drug Delivery. Adv Mater 2022;34:e2106865. [PMID: 34695275 DOI: 10.1002/adma.202106865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ness JR, Molvar C. Radioembolization of Intrahepatic Cholangiocarcinoma: Patient Selection, Outcomes, and Competing Therapies. Semin Intervent Radiol 2021;38:438-44. [PMID: 34629711 DOI: 10.1055/s-0041-1735526] [Reference Citation Analysis]
14 Murali N, Mouli SK, Riaz A, Lewandowski RJ, Salem R. Extrahepatic Applications of Yttrium-90 Radioembolization. Semin Intervent Radiol 2021;38:479-81. [PMID: 34629717 DOI: 10.1055/s-0041-1735573] [Reference Citation Analysis]
15 Borgia M, Dal Bo M, Toffoli G. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4387. [PMID: 34503196 DOI: 10.3390/cancers13174387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Gao Y, Lyu L, Feng Y, Li F, Hu Y. A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents. Int J Med Sci 2021;18:3066-81. [PMID: 34400877 DOI: 10.7150/ijms.59930] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
17 Alem Z, Murray TE, Egri C, Chung J, Liu D, Elsayes KM, Chang SD, Harris A. Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:3596-614. [PMID: 33909092 DOI: 10.1007/s00261-021-03095-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Van BJ, Dewaraja YK, Sangogo ML, Mikell JK. Y-90 SIRT: evaluation of TCP variation across dosimetric models. EJNMMI Phys 2021;8:45. [PMID: 34114115 DOI: 10.1186/s40658-021-00391-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Bouvry C, Ardisson V, Noiret N, Garin E, Lepareur N. Labeling of Hinokitiol with 90Y for Potential Radionuclide Therapy of Hepatocellular Carcinoma. Processes 2021;9:940. [DOI: 10.3390/pr9060940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Baikovitz JB, Thornton L, Garcia-Buitrago MT, Livingstone AS, Studenski MT, Portelance L. Pathologic validation of an yttrium-90 trans-arterial radioembolization dosimetry: a case report. J Surg Case Rep 2021;2021:rjab078. [PMID: 33959251 DOI: 10.1093/jscr/rjab078] [Reference Citation Analysis]
21 Herrero Álvarez N, Bauer D, Hernández-Gil J, Lewis JS. Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer. ChemMedChem 2021. [PMID: 33792195 DOI: 10.1002/cmdc.202100135] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
22 Badar W, Van Ha T, Zangan S, Navuluri R, Pillai A, Baker T, Dalag L, Han R, Ahmed O. Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory. Br J Radiol 2021;94:20200752. [PMID: 33411569 DOI: 10.1259/bjr.20200752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Qian Y, Liu Q, Li P, Han Y, Zhang J, Xu J, Sun J, Wu A, Song S, Lu W. Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization. ACS Nano 2021;15:2933-46. [PMID: 33529007 DOI: 10.1021/acsnano.0c09122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
24 Cassinotto C, Nogue E, Morell M, Panaro F, Molinari N, Guiu B. Changing trends in hepatocellular carcinoma management: Results from a nationwide database in the last decade. Eur J Cancer 2021;146:48-55. [PMID: 33582392 DOI: 10.1016/j.ejca.2021.01.009] [Reference Citation Analysis]
25 Li R, Li D, Jia G, Li X, Sun G, Zuo C. Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer. Front Oncol 2020;10:551622. [PMID: 33569342 DOI: 10.3389/fonc.2020.551622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zhang Q, Xu X, Wu M, Qin T, Wu S, Liu H. MiRNA Polymorphisms and Hepatocellular Carcinoma Susceptibility: A Systematic Review and Network Meta-Analysis. Front Oncol 2020;10:562019. [PMID: 33542895 DOI: 10.3389/fonc.2020.562019] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Thomas MA, Mahvash A, Abdelsalam M, Kaseb AO, Kappadath SC. Planning dosimetry for 90 Y radioembolization with glass microspheres: Evaluating the fidelity of 99m Tc-MAA and partition model predictions. Med Phys 2020;47:5333-42. [PMID: 32790882 DOI: 10.1002/mp.14452] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
28 Helmberger T. The evolution of interventional oncology in the 21st century. Br J Radiol 2020;93:20200112. [PMID: 32706978 DOI: 10.1259/bjr.20200112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, Gambhir SS, Hricak H, Weissleder R. Radiotheranostics: a roadmap for future development. Lancet Oncol 2020;21:e146-56. [PMID: 32135118 DOI: 10.1016/S1470-2045(19)30821-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 13.5] [Reference Citation Analysis]
30 Nabrinsky E, James E. Highlighting Survival with Yttrium-90 Radioembolization Therapy in Unresectable Hepatocellular Carcinoma. Cureus 2020;12:e8163. [PMID: 32550079 DOI: 10.7759/cureus.8163] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Pigg N, Aboubechara D, Fourzali R, Baigorri B. Yttrium-90 Radioembolization of Metastatic Adrenocortical Carcinoma to the Liver following Systemic Chemotherapy and Surgical Resection of the Primary Lesion. Case Rep Oncol 2020;13:158-63. [PMID: 32231538 DOI: 10.1159/000504779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
32 Yang HY, Jin B, Xu G, Sun LJ, Du SD, Mao YL. Transarterial radioembolization with Yttrium-90: current status and future prospects. Gastroenterol Rep (Oxf) 2020;8:164-5. [PMID: 32280478 DOI: 10.1093/gastro/goz074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Birgin E, Rasbach E, Seyfried S, Rathmann N, Diehl SJ, Schoenberg SO, Reissfelder C, Rahbari NN. Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with 90Y-Microspheres: A Systematic Review. Cancers (Basel). 2020;12. [PMID: 32012709 DOI: 10.3390/cancers12020294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
34 Abdel-Rahman O, Elsayed Z. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev 2020;1:CD011313. [PMID: 31978267 DOI: 10.1002/14651858.CD011313.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
35 Hinrichs JB, Wacker FK. [Locoregional and local ablative treatment options for liver tumors]. Internist (Berl) 2020;61:158-63. [PMID: 31919532 DOI: 10.1007/s00108-019-00725-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Ezponda A, Rodríguez-Fraile M, Morales M, Vivas I, De La Torre M, Sangro B, Bilbao JI. Hepatic Flow Redistribution is Feasible in Patients with Hepatic Malignancies Undergoing Same-Day Work-Up Angiography and Yttrium-90 Microsphere Radioembolization. Cardiovasc Intervent Radiol 2020;43:987-95. [PMID: 31848672 DOI: 10.1007/s00270-019-02371-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
37 Lee EJ, Chung HW, Jo JH, So Y. Radioembolization for the Treatment of Primary and Metastatic Liver Cancers. Nucl Med Mol Imaging 2019;53:367-73. [PMID: 31867071 DOI: 10.1007/s13139-019-00615-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
38 Ludwig AD, Labadie KP, Seo YD, Hamlin DK, Nguyen HM, Mahadev VM, Yeung RS, Wilbur DS, Park JO. Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma. J Oncol 2019;2019:4564707. [PMID: 31636665 DOI: 10.1155/2019/4564707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Li W, Ni CF. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma. Abdom Radiol (NY) 2019;44:2268-75. [PMID: 31016345 DOI: 10.1007/s00261-019-01943-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]